NDC 21130-564

safeway acid reducer

Lansoprazole

safeway acid reducer is a Oral Capsule, Delayed Release in the Human Otc Drug category. It is labeled and distributed by Safeway. The primary component is Lansoprazole.

Product ID21130-564_a2694f4b-cb2c-4efa-b138-9e5b25a78ea1
NDC21130-564
Product TypeHuman Otc Drug
Proprietary Namesafeway acid reducer
Generic NameLansoprazole
Dosage FormCapsule, Delayed Release
Route of AdministrationORAL
Marketing Start Date2022-04-18
Marketing CategoryANDA /
Application NumberANDA202319
Labeler NameSafeway
Substance NameLANSOPRAZOLE
Active Ingredient Strength15 mg/1
Pharm ClassesInhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 21130-564-01

1 BOTTLE in 1 CARTON (21130-564-01) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE
Marketing Start Date2022-04-18
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "safeway acid reducer" or generic name "Lansoprazole"

NDCBrand NameGeneric Name
0113-7003Basic Care LansoprazoleLansoprazole
0113-7116basic care lansoprazoleLansoprazole
0113-0116Good Sense LansoprazoleLansoprazole
0113-0117Good Sense lansoprazoleLansoprazole
0113-1114Good Sense LansoprazoleLansoprazole
0093-3008LansoprazoleLansoprazole
0093-3009LansoprazoleLansoprazole
0093-7350LansoprazoleLansoprazole
0093-7351LansoprazoleLansoprazole
0067-6286PrevacidLansoprazole
0113-6002Prevacid 24 HRlansoprazole

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.